TEG-002

N/A

Report date: 2023/04/03 10:20:20

Base Information

Drug NameTEG-002
Drug Alias NameTEG-002GDT-002
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsOvarian NeoplasmsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGadeta BV
China Registration ClassN/A

Develop Information

Active CompaniesGadeta BV
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A